CFG
ABCL icon

Citizens Financial Group’s AbCellera Biologics ABCL Stock Holding History

Citizens Financial Group’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.66M Sell
211,890
-50,000
-19% -$244K 0.02% 333
2026
Q1 		$914K Hold
261,890
– – 0.01% 412
2025
Q4 		$896K Hold
261,890
– – 0.01% 421
2025
Q3 		$1.32M Buy
+261,890
New +$1.15M 0.02% 345
2024
Q4 		– Sell
-311,890
Closed -$811K – 579
2024
Q3 		$811K Hold
311,890
– – 0.02% 324
2024
Q2 		$923K Buy
+311,890
New +$1.18M 0.02% 280

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return

Citizens Financial Group's ABCL Position: Q2 2026 in Review

Citizens Financial Group reduced its AbCellera Biologics (ABCL) stake by 19% in Q2 2026, selling an estimated $244K and leaving 211,890 shares worth $1.66M. The position accounts for 0.02% of the portfolio, ranked #333.

Citizens Financial Group first reported a position in ABCL in Q2 2024 and has held it in 6 quarters since. 151 funds tracked by Wall St. Rank hold ABCL as of Q2 2026.

  • Citizens Financial Group held 211,890 shares of AbCellera Biologics worth $1.66M as of Q2 2026.
  • Citizens Financial Group sold 50,000 AbCellera Biologics shares in Q2 2026, an estimated $244K.
  • AbCellera Biologics made up 0.02% of Citizens Financial Group's portfolio in Q2 2026, its #333 holding.
  • Citizens Financial Group first reported a position in AbCellera Biologics in Q2 2024 and has held it in 6 quarters since.
  • 151 funds tracked by Wall St. Rank held AbCellera Biologics as of Q2 2026.

Based on Citizens Financial Group's 13F filing for Q2 2026, filed 7 Aug 2026.